معرفی
Joseph McEvoy is a Professor and holds the Case Distinguished Chair in Psychotic Disorders at the Medical College of Georgia, Augusta University. He is affiliated with the Department of Psychiatry and Health Behavior, where he contributes to clinical, research, and educational missions in psychiatry.
Education:
- MD in Medicine, Vanderbilt University, 1973
- BA in Biology/Biological Sciences, Manhattan College, 1969
Dr. McEvoy's research centers on psychotic disorders, particularly schizophrenia, with a focus on clozapine treatment, insomnia, adiponectin as a biomarker, and impaired insight. His work explores biological and psychological mechanisms underlying depression and suicidality in schizophrenia, with special attention to health disparities in African-American male populations. He integrates clinical neuroscience with pharmacological and metabolic research to improve patient outcomes.
His recent publications reflect a strong trend in understanding the anti-suicidal effects of clozapine through improved sleep, the role of adiponectin in mood symptoms, and methodological challenges in assessing insight in clinical trials. These studies span meta-analyses, biomarker research, and clinical trial design, emphasizing translational psychiatry.
Scientific Awards:
- Best Didactic Teacher Award, Augusta University, 2023
Dr. McEvoy is actively involved in teaching and public service. He teaches in the psychiatry curriculum and has been recognized for excellence in didactic instruction. He serves on the board of NAMI (2014–present) and conducts monthly case conferences at Danville State Hospital, contributing to community mental health education and clinical support. No formal grants are mentioned, but his sustained scholarship and service indicate ongoing academic engagement.
He is involved in clinical and research teams focused on psychotic disorders, though specific lab names or research centers are not detailed in the text. His work appears to be integrated within the Department of Psychiatry and Health Behavior’s clinical and research infrastructure.
